Showing results (71-80 of 81) with videos related to
Sort By:
Pageof 9
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 14, 2020
Spectrum and Incidence Trends of AIDS- and Non-AIDS-Defining Cancers between 2010 and 2015 in the French Dat'AIDS CohortIsabelle Poizot-Martin, Caroline Lions, Clotilde Allavena, et al.Journal for Immunotherapy of Cancer|August 23, 2024
Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort studyLambert Assoumou, Raghiatou Baldé, Christine Katlama, et al.Plos One|March 25, 2022
Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in FranceTeresa Rojas Rojas, Isabelle Poizot-Martin, David Rey, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2019
Multimorbidity in Elderly Persons According to the Year of Diagnosis of Human Immunodeficiency Virus Infection: A Cross-sectional Dat'AIDS Cohort StudyMarie Demontès, Sabrina Eymard Duvernay, Clotilde Allavena, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 2, 2024
Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: A French nationwide multicenter cohort study-ANRS0001s COV-POPARTPaul Loubet, Jean-Daniel Lelievre, Alexis François, et al.Cells|March 25, 2022
Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and CancerMarine Baron, Cathia Soulié, Armelle Lavolé, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 19, 2022
Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE)Alexandre Duvignaud, Edouard Lhomme, Racha Onaisi, et al.International Journal of Cancer|September 16, 2023
State of the science and future directions for research on HIV and cancer: Summary of a joint workshop sponsored by IARC and NCIEric A Engels, Meredith S Shiels, Ruanne V Barnabas, et al.Scientific Reports|February 19, 2022
Performances of rapid and connected salivary RT-LAMP diagnostic test for SARS-CoV-2 infection in ambulatory screeningFrancisco Santos Schneider, Laurence Molina, Marie-Christine Picot, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 28, 2021
An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19Florence Ader, Nathan Peiffer-Smadja, Julien Poissy, et al.Pageof 9